Troubled drug company Valeant handed second upgrade of the week

Stock rallies in strong volume, but is still down more than 70% in the year so far.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.